The Axbio R&D team consists of senior Silicon Valley entrepreneurs, executives, engineers and scientists. The core members come from leading international biotechnology and pharmaceutical companies. The team has extensive experience in creating high-tech companies, managing, operating, and developing, and successfully achieving listing or mergers and acquisitions. These companies include biotechnology and semiconductors and new materials.
There are about 20 people in the R&D team, covering multiple disciplines such as physics, chemistry, biology, and other fields, including integrated circuits, semiconductors, biochemistry, organic chemistry, surface physics, microfluidics, physical chemistry, biological information, big data, artificial intelligence, etc. Many senior experts. The age group is mainly 25-40 years old, and also includes several experienced experts and technical management talents of 40-65 years old. Among them, only the core members have obtained nearly one hundred authorized patents in the United States, and many patents are pending.